0.9199
0.49%
-0.0045
Seres Therapeutics Inc Azioni (MCRB) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
79.35%
0.064
|
0.31 | 126.47 | -0.522 | 0.975 |
Operating Expenses
|
17.04%
39.59
|
47.72 | 76.95 | 70.05 | 69.28 |
Benefits Costs and Expenses |
-
|
- | - | - | - |
Costs And Expenses |
17.04%
39.59
|
47.72 | 76.95 | 70.05 | 69.28 |
Operating Income/Loss |
16.63%
-39.53
|
-47.41 | 49.52 | -70.57 | -68.31 |
Nonoperating Income/Loss |
290.48%
-1.722
|
-0.441 | -2.972 | -0.606 | -0.489 |
Income/Loss From Continuing Operations Before Tax |
79.35%
0.064
|
0.31 | 46.55 | -71.17 | 0.975 |
Income Tax Expense/Benefit |
-
|
- | - | - | - |
Income/Loss From Continuing Operations After Tax |
13.80%
-41.25
|
-47.85 | 46.55 | -71.17 | -68.80 |
Net Income/Loss
|
13.80%
-41.25
|
-47.85 | 46.55 | -71.17 | -68.80 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
99.45%
0.7056
|
128.29 | 127.71 | 125.86 | 5.6963 |
Diluted Average Shares |
99.45%
0.7056
|
128.29 | 129.84 | 125.86 | 5.6963 |
Basic Earnings Per Share |
13.51%
-0.32
|
-0.37 | 0.36 | -0.57 | -0.54 |
Diluted Earnings Per Share |
13.51%
-0.32
|
-0.37 | 0.36 | -0.57 | -0.54 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Capitalizzazione:
|
Volume (24 ore):